21000 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Growth hormone [GH] (Somatotropin)
Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
#602Modified Human Interferon Polypeptides and Their Uses
#603Modified Human Interferon Polypeptides and Their Uses
#604Modified human growth hormone formulations with an increased serum half-life
#605Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#606Formulations of human growth hormone comprising a non-naturally encoded amino acid
#607Modified Human Growth Hormone Polypeptides and Their Uses
#608Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses
#609Method and apparatus for producing dry particles
#610Modified Human Growth Hormone
#611Modified Human Growth Hormone Polypeptides and Their Uses
#612Modified Human Growth Hormone Polypeptides and Their Uses
#613Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
#614Modified human growth hormone
#615Modified Human Growth Hormone
#616Microparticles and Nanoparticles for the Transmucosal Delivery of Therapeutic and Diagnostic Agents
#617Modified human four helical bundle polypeptides and their uses
#618HUMAN GROWTH HORMONE FORMULATIONS
#619Sustained release formulation
#620Liquid depot formulations
#621Medical compositions containing ghrelin
#622Methods And Compositions For The Treatment Of Prolactin-Receptor Related Disorders
#623Liquid growth hormone formulation and method of use
#624Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
#625TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY
#626Recombinant fusion proteins to growth hormone and serum albumin
#627Stabilizing alkylglycoside compositions and methods thereof
#628Transdermal System for Sustained Delivery of Polypeptides
#629Sialic acid derivatives
#630Hydrophobic biomolecular structure
#631Compositions capable of facilitating penetration across a biological barrier
#632Remedy for Cartilage-Related Diseases
#633Opioid depot formulations
#634Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
#635Growth hormone receptor antagonist cancer treatment
#636Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
#637Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
#638COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#639Methods and compositions for treating post-myocardial infarction damage
#640Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration
#641Nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans
#642Sialic acid derivatives for protein derivatisation and conjugation
#643Salts of potassium ATP channel openers and uses thereof
#644Pharmaceutical Formulation
#645Induction of tolerance by oral administration of factor VIII and treatment of hemophilia
#646In-Situ Forming Porous Scaffold
#647Preparations of growth hormone
#648Compositions capable of facilitation penetration across a biological barrier
#649Transdermal and transmucosal preparations
#650Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same
#651Methods and compositions for the treatment of lipodystrophy
#652Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
#653Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#654Human growth hormone patch formulations
#655Polymeric delivery agents and delivery agent compounds
#656Growth hormone-containing formulation and method of use
#657Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue
#658Transglutaminase mediated conjugation of peptides
#659Injection vehicle for polymer-based formulations
#660Compounds and compositions for delivering active agents
#661Liposomal vaccine
#662Skin conditions using human growth hormone
#663Buffered drug formulations for transdermal electrotransport delivery
#664METHOD OF ENHANCING TRANSMUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS
#665Microfabricated nanopore device for sustained release of therapeutic agent
#666Compositions and methods for treatment of muscle pain and muscle wasting
#667Use of human growth hormone in multiple system atrophy
#668Liquid formulations with high concentration of human growth hormone (high) comprising glycine
#669Liposomal vaccine
#670Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#671Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#672Enhanced method of treatment of growth disorders
#673Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#674Human growth hormone aqueous formulation
#675GHRP 2 strips
#676Composition and its Therapeutic Use
#677Complexation of metal ions with polypeptides
#678Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol
#679Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#680Dressing
#681Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#682Methods and compositions for treating degenerative bone disorders
#683Somatogenic therapy using a 20kda placental variant of growth hormone
#684Stable topical drug delivery compositions
#685Conjugates formed from polymer derivatives having particular atom arrangements
#686Sustained-release microparticle preparation of human growth hormone and process for producing thereof
#687Long-acting molecules in sustained release formulations
#688Liquid growth hormone formulation and process of preparation thereof
#689Method of treating intestinal disorders with citrulline
#690Sustained release pharmaceutical composition
#691Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
#692Repair and regeneration of ocular tissue using postpartum-derived cells
#693Conjugates of an hGH moiety and a polymer
#694Compositions for nasal administration of pharmaceuticals
#695Absorption enhancers such as e.g. BHT, BHA or propyl gallate
#696Intracutaneous injection
#697Zinc-containing sustained-release composition, its preparation, and method for producing the same
#698Solvent/polymer solutions as suspension vehicles
#699Modified human growth horomone polypeptides and their uses
#700Treatment of diabetes
#701Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#702Pharmaceutical formulations for sustained drug delivery
#703Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
#704Reversible pegylated drugs
#705Medical compositions containing ghrelin
#706Compounds and compositions for delivering active agents
#707SHORT DURATION DEPOT FORMULATIONS
#708Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol
#709Cartilage and bone repair and regeneration using postpartum-derived cells
#710Method of differentiating umbilical cord tissue into a chondrogenic phenotype
#711Cartilage and bone repair and regeneration using postpartum-derived cells
#712Cartilage and bone repair and regeneration using postpartum-derived cells
#713Soft tissue repair and regeneration using postpartum-derived cells and cell products
#714Methods and compositions for needleless delivery of macromolecules
#715Glycoproteins produced in plants and methods of their use
#716Effect of growth hormone and IGF-1 on neural stem cells
#717Novel metabolic targets and markers
#718Stable aerosol formulations of peptides and protein with non-cfc propellants
#719Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
#720Human growth hormone conjugated with biocompatible polymer
#721Oral drug delivery compositions and methods
#722Methods of delivering stable topical drug compositions
#723Methods and preparations for curing critically ill patients
#724Uptake of macromolecules
#725Combined regulation of neural cell production
#726Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
#727Topical drug delivery using phosphatidylcholine
#728Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
#729Pharmaceutical compositions for sustained drug delivery
#730Dispersant for sustained release preparations
#731Use of autogenous growth factors in bone tunnels during ligament reconstruction
#732Methods of determining contributions to metabolic pathways
#733Treatment of congestive heart failure
#734Human growth hormone treatment methods
#735Treatment of obesity
#736Low molecular weight peptidomimetic growth hormone secretagogues
#737Polypeptide delivery system
#738Method and apparatus for producing dry particles
#739Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
#740Growth hormone formulations
#741Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
#742Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
#743Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases
#744Gel composition and methods
#745Slow release protein polymers
#746Excipients in drug delivery vehicles
#747Compounds and compositions for delivering active agents
#748Human growth hormone aqueous formulation
#749NF-kappaB activation inhibitors, and their pharmaceutical uses
#750High molecular weight medicine-containing preparation in powder form for administration through mucosa
#751Medicinal Agent for Preventing and Treating Endocrine System Disturbances
#752Hydrophobic biomolecular structure
#753Active agent transport systems
#754Use of citrulline within the framework of intestinal insufficiency
#755Modified human interferon polypeptides and their uses
#756Method for selectively inhibiting ghrelin action
#757Method for control of depression using c terminal growth hormone (gh) fragment
#758Compounds and compositions for delivering active agents
#759Treatment of type i diabetes mellitus
#760Nanoparticulate therapeutic biologically active agents
#761Treatment of congestive heart failure
#762Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety
#763Human growth hormone modified at position 35
#764Liposomal vaccine
#765Growth promoting pharmaceutical implant
#766Method for administration of growth hormone via pulmonary delivery
#767Therapeutical conversion
#768Macromolecular drug complexes having improved stability and therapeutic use of the same
#769Methods compositions and articles of manufacture for modulating bone growth
#770Treatment of congestive heart failure
#771Surfactant-based gel as an injectable, sustained drug delivery vehicle
#772Compounds and compositions for delivering active agents
#773Delivery of drugs to the bloodstream in toothpaste
#774Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
#775Stabilized reverse micelle compositions and uses thereof
#776Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#777Compositions capable of facilitating penetration across a biological barrier
#778Postpartum cells derived from placental tissue, and methods of making and using the same
#779Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#780Soft tissue repair and regeneration using postpartum-derived cells
#781Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
#782Therapy for growth hormone induced insulin resistance in juveniles with growth disorders
#783Treatment of retinitis pigmentosa with human umbilical cord cells
#784Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
#785Regeneration and repair of neural tissue using postpartum-derived cells
#786Compositions and methods for enhanced mucosal delivery of growth hormone
#787Delivery of therapeutic gene products by intestinal cell expression
#788Sustained release pharmaceutical composition
#789Cartilage and bone repair and regeneration using postpartum-derived cells
#790Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
#791Treatment of congestive heart failure
#792Chemical and physical modulators of bioavailability of inhaled compositions
#793Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment
#794Fragments of growth hormone binding protein